Clinical Trial Update: Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PF-07038124 ointment for atopic dermatitis and plaque psoriasis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Plaque Psoriasis

Drugs mentioned

• PF-07038124 ointment (PF-07038124)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-26